A novel strain of gonorrhea has been detected in a Massachusetts resident, according to state health officials who called this a “serious public health concern.”
The state Department of Public Health today announced it has detected a “concerning” novel strain of gonorrhea in a resident that showed reduced response to multiple antibiotics, and another case with genetic markers that indicate a similar drug response.
This is the first time that resistance or reduced response to five classes of antibiotics has been identified in gonorrhea in the U.S.
“The discovery of this strain of gonorrhea is a serious public health concern which DPH, the CDC, and other health departments have been vigilant about detecting in the US,” said Public Health Commissioner Margret Cooke.
“We urge all sexually active people to be regularly tested for sexually transmitted infections and to consider reducing the number of their sexual partners and increasing their use of condoms when having sex,” Cooke added. “Clinicians are advised to review the clinical alert and assist with our expanded surveillance efforts.”
Both cases in Massachusetts were successfully cured with ceftriaxone, the antibiotic currently recommended to treat gonorrhea. To date, no direct connection between the two individuals has been identified.
Gonorrhea is a bacterial sexually transmitted infection. It may present without symptoms, and if left untreated, can result in pelvic inflammatory disease, infertility, and other health problems.
This strain of gonorrhea has been previously seen in Asia-Pacific countries and in the United Kingdom, but not in the U.S.
A genetic marker common to these two Massachusetts residents was also previously seen in a case in Nevada, though that strain retained sensitivity to at least one class of antibiotics. Overall, these cases are an important reminder that strains of gonorrhea in the US are becoming less responsive to a limited arsenal of antibiotics.
The Massachusetts cases were detected by DPH’s State Public Health Laboratory as part of disease surveillance activities. Field epidemiologists in DPH’s Division of Sexually Transmitted Disease Prevention are conducting contact tracing to determine if other individuals have acquired this infection.
Working with the CDC and local hospitals and health centers, DPH is expanding its testing of gonorrhea specimens for evidence of this strain in other patients.
Gonorrhea has been increasing in Massachusetts and nationally, adding to concerns about the potential spread of this strain which is more difficult to treat. In Massachusetts, laboratory-confirmed cases of gonorrhea have increased 312% since a low point of 1,976 cases in 2009 to 8,133 in 2021.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health & Fitness News Click Here
